| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 18,600 | 19,500 | 06.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Getinge Q4 2025: Gewinn übertrifft Erwartungen, Umsatz und Aktie unter Druck | 1 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 2025: Organisches Wachstum trotz Währungs- und Zollbelastungen | 2 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 2025 slides: organic growth persists amid FX and tariff headwinds | 1 | Investing.com | ||
| 27.01. | Getinge im vierten Quartal 2025: Währungs- und Zolleffekte schmälern die Marge | 4 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 Net Profit Up, But Sales & Order Intake Down; Sees Organic Sales Growth In FY26 | 270 | AFX News | STOCKHOLM (dpa-AFX) - Swedish medical technology company Getinge AB (GNGBF, GETI-B.ST) on Tuesday reported higher net profit in its fourth quarter, despite weak net sales. Order intake also... ► Artikel lesen | |
| 27.01. | Getinge AB Q4 Profit Climbs | 297 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at SEK868 million, or SEK3.19... ► Artikel lesen | |
| 27.01. | Getinge AB Non-GAAP EPS of SEK 4.45, revenue of SEK 10.19B; initiates FY26 outlook | 3 | Seeking Alpha | ||
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 27.01. | Getinge AB: Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year | 187 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on January 27, 2026
"We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for... ► Artikel lesen | |
| 13.01. | Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call | 14 | Cision News | ||
| 19.12.25 | Getinge transforms sterile reprocessing with Automatiq - a full range of logistic automation modules | 8 | Cision News | ||
| 18.12.25 | Camilla Sylvest is proposed for Getinge AB's Board of Directors | 2 | Cision News | ||
| 25.11.25 | Getinge and SteriPro International Inc. announce strategic partnership for sterile processing optimization | 1 | Cision News | ||
| 20.11.25 | Getinge introduces new version of Solsus 66 to meet CSSD efficiency needs | 4 | Cision News | ||
| 13.11.25 | GETINGE: Utility-efficient washer-disinfector Aquadis 44 helps hospitals reduce costs and meet environmental targets | 1 | Cision News | ||
| 04.11.25 | Getinge boosts cleanroom efficiency with modern interface for cGMP washers and sterilizers | 2 | Cision News | ||
| 21.10.25 | Getinge Q3 Profit Surges; Confirms Annual Outlook | 485 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST), a medtech company, on Tuesday reported a profit before tax of SEK 789 million for the third quarter, a sharp increase from SEK 32 million in the... ► Artikel lesen | |
| 21.10.25 | Getinge-Aktie steigt nach übertroffenen Quartalsergebnissen | 25 | Investing.com Deutsch | ||
| 21.10.25 | Getinge AB Non-GAAP EPS of SEK 2.42, revenue of SEK 8.23B; reaffirms FY outlook | 13 | Seeking Alpha | ||
| 21.10.25 | Getinge AB: Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds | 207 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on October 21, 2025
"We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs... ► Artikel lesen | |
| 13.10.25 | Getinge's Advanta V12 receives CE Mark for major bridging indications | 2 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| ESSILORLUXOTTICA | 257,60 | +0,12 % | JEFFERIES stuft EssilorLuxottica auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat EssilorLuxottica auf "Buy" mit einem Kursziel von 350 Euro belassen. Nachdem die Aktie wegen Bedenken um die Margen, unangebrachter Wettbewerbssorgen... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 158,00 | -0,47 % | Align Technology Inc. Announces Increase In Q4 Bottom Line | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) reported a profit for its fourth quarter that Increases, from last yearThe company's earnings came in at $135.76 million, or $1.89 per share.... ► Artikel lesen | |
| INMODE | 12,705 | -0,47 % | InMode gains as it evaluates strategic alternatives | ||
| ELEVANCE HEALTH | 280,40 | -2,20 % | Elevance Health, Inc. - 10-K, Annual Report | ||
| BONESUPPORT | 16,180 | -0,25 % | AKTIONÄR-Tipp Bonesupport: Befreiungsschlag - kräftiges Wachstum in Sicht | Wachstumssorgen haben die Aktie von Bonesupport in den zurückliegenden Monaten massiv belastet. Ausgehend vom Rekordhoch verlor das Papier des Orthobiologie-Spezialisten zeitweise mehr als die Hälfte.... ► Artikel lesen | |
| TENET | 170,00 | -0,58 % | Where Tenet Healthcare Stands With Analysts | ||
| ARJO | 2,450 | -4,07 % | Mitsu Chem Plast gains after being onboarded as global supplier to Arjo | ||
| AMN HEALTHCARE SERVICES | 17,600 | +2,33 % | AMN HEALTHCARE SERVICES INC - 8-K, Current Report | ||
| OSSDSIGN | 0,610 | -0,16 % | OssDsign AB: OssDsign AB (publ) publishes year-end report 2025 | Strong growth and real-world data set the stage for U.S. market expansion
OssDsign AB (publ) announces that the year-end report for 2025 is now available as a PDF on the company's website www.ossdsign.com/reports.... ► Artikel lesen | |
| CHECK-CAP | 1,310 | -5,07 % | Check-Cap Ltd - F-1/A, Registration statement for certain foreign private issuers | ||
| ALPHATEC | 11,615 | -0,77 % | Alphatec Holdings, Inc. and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion | ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 19,900 | -0,50 % | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Initial Disclosure Notice - Ordinary Shares | ||
| STEREOTAXIS | 1,730 | 0,00 % | Stereotaxis, Inc.: Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter | ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 7,600 | +3,40 % | Citizens maintains Cross Country Healthcare stock rating, cites discount to peer |